Use of Pharmacologic Agents for the Prevention of Osteoporosis Among Older Women with Low Bone Mass Is Discordant with National Osteoporosis Foundation Guidance

被引：0
|
作者：
Zhang, Jie [1 ]
Curtis, Jeffery R. [1 ]
Delzell, Elizabeth S. [1 ]
Saag, Kenneth G. [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1121
引用
收藏
页码：S438 / S438
页数：1
相关论文
共 50 条
  • [31] Prevalence of primary osteoporosis and low bone mass in postmenopausal women and related risk factors
    Hemmati, Elnaz
    Mirghafourvand, Mojgan
    Mobasseri, Majid
    Shakouri, Seyed Kazem
    Mikaeli, Parvaneh
    Farshbaf-Khalili, Azizeh
    JOURNAL OF EDUCATION AND HEALTH PROMOTION, 2021, 10 (01)
  • [32] Effects of Arzoxifene on Breast Cancer Incidence in Postmenopausal Women with Osteoporosis or with Low Bone Mass
    Powles, T.
    Diem, S.
    Wickerham, L.
    Cox, D.
    Amewou-Atisso, M.
    Agnusdei, D.
    Murain, D.
    Mitlak, B.
    Cummings, S.
    CANCER RESEARCH, 2009, 69 (24) : 499S - 499S
  • [33] Low Bone Mass is Associated with Stroke in Chinese Postmenopausal Women: The Chongqing Osteoporosis Study
    Rui Zhou
    Dong Liu
    Rui Li
    Shiming Zhou
    Min Cui
    Lin Chen
    Huadong Zhou
    Cell Biochemistry and Biophysics, 2015, 71 : 1695 - 1701
  • [34] Polymorphism of vitamin D receptor gene, bone mass, and bone turnover among women with postmenopausal osteoporosis
    Garrofé, RF
    Fornés, CG
    Montané, MB
    Crespillo, CA
    del Pozo, AP
    Ortega, JV
    Jurado, CR
    REVISTA CLINICA ESPANOLA, 2000, 200 (04): : 198 - 202
  • [35] Differences in site-specific fracture risk among older women with discordant results for osteoporosis at hip and spine.
    Fink, H
    Litwack-Harrison, S
    Taylor, B
    Ensrud, K
    Schousboe, J
    Stone, K
    Black, D
    Cummings, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S88 - S88
  • [36] IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women
    Liu, Jian-min
    Zhao, Hong-yan
    Ning, Guang
    Chen, Ying
    Zhang, Lian-zhen
    Sun, Li-hao
    Zhao, Yong-ju
    Xu, Man-yin
    Chen, Jia-lun
    JOURNAL OF BONE AND MINERAL METABOLISM, 2008, 26 (02) : 159 - 164
  • [37] IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women
    Jian-min Liu
    Hong-yan Zhao
    Guang Ning
    Ying Chen
    Lian-zhen Zhang
    Li-hao Sun
    Yong-ju Zhao
    Man-yin Xu
    Jia-lun Chen
    Journal of Bone and Mineral Metabolism, 2008, 26 : 159 - 164
  • [38] Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults (vol 176, pg 224, 2023)
    Qaseem, A.
    Hicks, L. A.
    Etxeandia-Ikobaltzeta, I.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (06) : 882 - 884
  • [39] Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis
    Burshell, Alan L.
    Song, Jingli
    Dowsett, Sherie A.
    Mershon, John L.
    Delmas, Pierre D.
    Secrest, Roberta J.
    Cauley, Jane A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (03) : 807 - 813
  • [40] Controversies in Osteoporosis Management: How Do You Treat a Newly Menopausal Woman With Low Bone Mass: When and How Is It Appropriate to Provide Pharmacologic Intervention to Prevent Osteoporosis?
    Jiang, Xuezhi
    Kagan, Risa
    Schnatz, Peter F.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2013, 56 (04): : 739 - 742
12345